$TVTX 8-K SEC Filings

Filed On	Filing
21 Sep 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers THIS EMPLOYMENT AGREEMENT is entered into by and between Travere Therapeutics, Inc., a Delaware corporation (hereinafter the “Company”), and Bradley Campbell (hereinafter “Executive”).
04 Aug 2026	8-K: Results of Operations and Financial Condition
09 Jul 2026	8-K: Departure/Election of Directors or Officers; Compensation
16 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation
02 Jun 2026	8-K: Entry into a Material Definitive Agreement
21 May 2026	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
11 May 2026	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +2 more
04 May 2026	8-K: Results of Operations and Financial Condition
14 Apr 2026	8-K: Other Events
19 Feb 2026	8-K: Results of Operations and Financial Condition
13 Jan 2026	8-K: Other Events
12 Jan 2026	8-K: Results of Operations and Financial Condition
30 Oct 2025	8-K: Results of Operations and Financial Condition
10 Sep 2025	8-K: Other Events
06 Aug 2025	8-K: Results of Operations and Financial Condition
16 May 2025	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
15 May 2025	8-K: Other Events
01 May 2025	8-K: Completion of Acquisition or Disposition of Assets
30 Apr 2025	8-K: Other Events
17 Mar 2025	8-K: Other Events

Comments